logo
Select company
Select metric
Ticker Information

Ticker

ARCT

Company Name

ARCTURUS THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARCTURUS THERAPEUTICS HOLDINGS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARCT - FCF/OCF Historical data
DateFree Cash FlowFree Cash Flow to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ -65.16M0%$ -64.94M
3/31/2025$ -89.87M0%$ -89.33M
12/31/2024$ -60.4M0%$ -59.75M
9/30/2024$ -61.62M0%$ -60.09M
6/30/2024$ -71.16M0%$ -68.73M
3/31/2024$ 9.77M79.94%$ 12.21M
12/31/2023$ -21M0%$ -18.1M
9/30/2023$ 136.96M95.91%$ 142.79M
6/30/2023$ 125.75M94.7%$ 132.79M
3/31/2023$ 38.85M86.04%$ 45.16M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARCTURUS THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) FCF/OCF stands at 0%.
  • Over the past 5 years, ARCTURUS THERAPEUTICS HOLDINGS INC's average FCF/OCF has been 86.49%.
  • The median FCF/OCF for ARCTURUS THERAPEUTICS HOLDINGS INC during this period was 86.04%
  • ARCTURUS THERAPEUTICS HOLDINGS INC reached its highest FCF/OCF over the past 5 years at 95.91%.
  • The lowest FCF/OCF recorded by ARCTURUS THERAPEUTICS HOLDINGS INC in the same timeframe 75.85%

ARCTURUS THERAPEUTICS HOLDINGS INC's FCF/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF/OCF Benchmarks
CompanyFCF/OCF
CTMX : CYTOMX THERAPEUTICS INC -ADCT : ADC THERAPEUTICS SA -YMAB : Y-MABS THERAPEUTICS INC -RGNX : REGENXBIO INC -HRTX : HERON THERAPEUTICS INC -GLUE : MONTE ROSA THERAPEUTICS INC 86.06%TRDA : ENTRADA THERAPEUTICS INC -CDXS : CODEXIS INC -LFCR : LIFECORE BIOMEDICAL INC -STIM : NEURONETICS INC -

Definition of Free Cash Flow to Operating Cash Flow

[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
FCF / CF - Operations
(=) FCF/OCF
FCF/OCF for ARCTURUS THERAPEUTICS HOLDINGS INC is calculated as follows: FCF [ $ -45.13M ] / CF - Operations [ $ -43.77M ]
(=) FCF/OCF [ 0% ]

ARCT - Free Cash Flow to Operating Cash Flow, Last 5 years

75.85%

Minimum

Dec 31, 2022

95.91%

Maximum

Sep 30, 2023

86.49%

Average

86.04%

Median

FCF/OCF Benchmark Analysis

The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.44% with a standard deviation of 29.12%.
The following table provides additional summary stats:
FCF/OCF in the Market:
filtered constituents2.51K
min-23%
max171.58%
average71.44%
median80.83%
std29.12%